Seneste opdatering :
03/05/2024
Infostab
Lister
Bversigter
Søg efter kompatibilitet
Y-site kompatibilitetstabel
Bibliografi
Forskerhold
Valistab
Poster
Links
Sponsorer
Forfatter
Brugervejledning
Nyhedsbrev
Bibliografi 1606
Type :
Journal
Forskerhold :
Bethesda - National Institutes of Health Clinical Center
Forfattere :
Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.
Titel :
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Nummer :
Am J Health-Syst Pharm ; 58: 594-598. 2001
Cotationvaleur :
Fysisk stabilitet :
Kemisk stabilitet :
Andre metoder :
Kommentarer :
Nedbrydningsprodukter konstateret, men ikke kvantificeret
Lister
Doxorubicin hydrochloride
Etoposide phosphate
Vincristine sulfate
2-6°C
Doxorubicin hydrochloride
0,12 mg/ml
Etoposide phosphate
0,6 mg/ml
Vincristine sulfate
0,005 mg/ml
5
2-6°C
Doxorubicin hydrochloride
0,24 mg/ml
Etoposide phosphate
1,2 mg/ml
Vincristine sulfate
0,010 mg/ml
5
2-6°C
Doxorubicin hydrochloride
0,4 mg/ml
Etoposide phosphate
2 mg/ml
Vincristine sulfate
0,016 mg/ml
5
35°C-40°C
Doxorubicin hydrochloride
0,12 mg/ml
Etoposide phosphate
0,6 mg/ml
Vincristine sulfate
0,005 mg/ml
5
35°C-40°C
Doxorubicin hydrochloride
0,24 mg/ml
Etoposide phosphate
1,2 mg/ml
Vincristine sulfate
0,010 mg/ml
5
35°C-40°C
Doxorubicin hydrochloride
0,4 mg/ml
Etoposide phosphate
2 mg/ml
Vincristine sulfate
0,016 mg/ml
5
Mentions Légales